menu
    • menu

    Company profile for CorePharma, LLC

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    CorePharma, founded in 1998, is a developer, manufacturer and marketer of high-quality, targeted, generic prescription pharmaceuticals across a variety of dosage forms and therapeutic categories. We specialize in difficult-to-develop high value products across a variety of therapeutic areas and currently produce almost one-half billion tablets and capsules annually. Our expertise in product development and manufacturing is com...
    CorePharma, founded in 1998, is a developer, manufacturer and marketer of high-quality, targeted, generic prescription pharmaceuticals across a variety of dosage forms and therapeutic categories. We specialize in difficult-to-develop high value products across a variety of therapeutic areas and currently produce almost one-half billion tablets and capsules annually. Our expertise in product development and manufacturing is complemented by robust sales, marketing and distribution capabilities.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    CorePharma, LLCUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    215 Wood Avenue, Middlesex, NJ 08846
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.corepharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    CorePharma's Generic Dicyclomine Hydrochloride Receives Approval in the U.S.
    CorePharma's Generic Dicyclomine Hydrochloride Receives Approval in the U.S.

    28 Nov 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216760

    FDA
    28 Nov 2022
    Share Share
    Another Example Of A “Shkrelian” Drug Price Increase
    Another Example Of A “Shkrelian” Drug Price Increase

    29 Oct 2022

    // John LaMattina FORBES

    https://www.forbes.com/sites/johnlamattina/2022/10/28/another-example-of-a-shkrelian-drug-price-increase/?sh=3394eb16f003

    John LaMattina FORBES
    29 Oct 2022
    Share Share
    CorePharma's Generic Chlorzoxazone Receives Approval in the U.S.
    CorePharma's Generic Chlorzoxazone Receives Approval in the U.S.

    20 Oct 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214941

    FDA
    20 Oct 2022
    Share Share
    CorePharma's Generic Chlordiazepoxide HCL;Clidinium Br Receives Approval in U.S.
    CorePharma's Generic Chlordiazepoxide HCL;Clidinium Br Receives Approval in U.S.

    29 Jul 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215453

    FDA
    29 Jul 2022
    Share Share
    CorePharma's Generic Clorazepate Dipotassium Receives Approval in the U.S.
    CorePharma's Generic Clorazepate Dipotassium Receives Approval in the U.S.

    14 Jun 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215566

    FDA
    14 Jun 2022
    Share Share
    CorePharma to reopen under new ownership following Impax sale
    CorePharma to reopen under new ownership following Impax sale

    31 Jan 2018

    // M. Fassbender OUTSOURCING

    https://www.outsourcing-pharma.com/Article/2018/01/31/CorePharma-to-reopen-under-new-ownership-following-Impax-sale

    M. Fassbender OUTSOURCING
    31 Jan 2018
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search